SCHEDULE 13G

Company

Celldex Therapeutics, Inc.

Filed

May 27, 2009

Accession Number

0000950123-09-009530

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →